2023-05-10 09:11:00
Technology, vast amounts of information, and advances in data science are creating opportunities to predict, prevent, and personalize treatments that were once unimaginable. Even a pessimistic estimate shows that the potential annual savings from the use of predictive medicine would amount to $26 billion worldwide, according to a report by strategy&, the global strategy department of the PwC network.
Ruxandra TârlescuPhoto: PwC Romania
US researchers have found that the use of precision molecular diagnostics or pharmacogenetics for six common conditions – cancer, diabetes, heart disease, hypertension, lung disease and stroke – has enormous potential for disease prevention by identifying people at risk and facilitating prophylactic therapy.
Thus, a 10% reduction in the incidence of disease through predictive medicine over the next 50 years would generate an economic value of between $33 billion and $114 billion, depending on the condition, in the form of longer, healthier lives, according to the PwC analysis. .
What does the transition to predictive medicine entail?
A well-developed predictive health system requires medical guidance of the population integrated into everyday life. This would include an understanding of the individual’s genetic predisposition to disease and risk factors, relevant epigenetic markers and biomarkers, preventive measures such as regular health and wellness scans and monitoring.
Read the rest of the article on the PwC Romania blog
Article signed by Ruxandra Târlescu, PwC Romania Partner
Article supported by PwC Romania
1683710893
#transition #traditional #healthcare #predictive #medicine #tools #recipe #change #missing #challenges